Pharmaceutical formulation
US4537887A · kind A · utility
21Cited by
3References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 1983 |
| Grant date | Aug 27, 1985 |
| Priority date | — |
| Expiry date | Oct 5, 2003 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A unit dose pharmaceutical composition suitable for oral administration which composition comprises a pharmaceutically acceptable carrier, a desiccant, amoxycillin trihydrate equivalent to 20 mg to 1500 mg of amoxycillin and potassium clavulanate equivalent to 20 mg to 500 mg of clavulanic acid, with the proviso that the weight ratio of amoxycillin to clavulanic acid is in the range 12:1 to 1:1; characterized in that the composition is in tablet form, wherein the desiccant is edible and incorporated within the tablets.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.